Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
In Vitro Diagnostic Solutions (IVDS) is a medical technology company specializing in point-of-care (POC) diagnostic tools for rare metabolic disorders and chronic conditions. The company's lead product, PKU Now, is a handheld monitoring device currently in Phase 3 clinical trials, designed to provide real-time blood phenylalanine levels for patients with Phenylketonuria (PKU). IVDS's proprietary platform combines a portable meter with specialized test strips and a smartphone application to deliver lab-quality results in minutes, facilitating better dietary compliance and patient outcomes. The company is also developing POC solutions for muscle health (CPK Now), tyrosinemia (Tyr Now), and G6PD deficiency (PreQuine Platform). Headquartered in New Jersey, IVDS leverages advanced microfluidics and assay technology to transform traditional laboratory testing into accessible, home-based monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on In Vitro Diagnostic Solutions.